Willingness and hesitancy towards the governmental free human papillomavirus vaccination among parents of eligible adolescent girls in Shenzhen, Southern China.

Publisher: BioMed Central Country of Publication: England NLM ID: 101088690 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6874 (Electronic) Linking ISSN: 14726874 NLM ISO Abbreviation: BMC Womens Health Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2001-

Papillomavirus Vaccines*/administration & dosage ; Parents*/psychology ; Papillomavirus Infections*/prevention & control ; Papillomavirus Infections*/psychology ; Patient Acceptance of Health Care*/psychology ; Patient Acceptance of Health Care*/statistics & numerical data ; Vaccination Hesitancy*/psychology ; Vaccination Hesitancy*/statistics & numerical data; Humans ; Female ; China ; Adolescent ; Cross-Sectional Studies ; Adult ; Vaccination/psychology ; Vaccination/statistics & numerical data ; Health Knowledge, Attitudes, Practice ; Surveys and Questionnaires ; Male ; Middle Aged ; Child ; Human Papillomavirus Viruses

Background: Since 2020, China has actively promoted HPV vaccination for eligible adolescent girls through various pilot programmes. This study investigated parental willingness and hesitancy towards the government-sponsored, free human papillomavirus (HPV) vaccination for eligible adolescent girls in Shenzhen, Southern China.
Methods: From June to August 2022, a cross-sectional survey was conducted with parents of girls entering Grade 7, employing an adapted Vaccine Hesitancy Scale to assess vaccine hesitancy and logistic regression to identify factors influencing willingness to accept the free domestic vaccines.
Results: Although only 3.4% of the 2856 respondents had their daughters vaccinated against HPV prior to the survey, 91.7% were willing to utilise the governmental vaccination services. Parents with children in public schools (χ ²  = 20.08, p < 0.001), those with more secure medical insurance (χ ²  = 4.97, p = 0.026), and parents who had received an HPV vaccine themselves (χ ²  = 28.829, p < 0.001) showed more reluctance towards the free vaccines. Vaccine hesitancy was presented in a mere 2.1% but was a significant predictor of vaccine refusal, even after adjusting for multiple factors (adjusted OR = 15.98, 95% CI: 9.06, 28.20). Notably, about four-fifths of parents of unvaccinated daughters harboured concerns about the safety and efficacy of the domestic vaccine.
Conclusions: Although parents show a strong inclination to utilise the government vaccination services, their vaccine hesitancy, driven by safety concerns and a preference for imported vaccines, remains a significant barrier for rolling out vaccination coverage. This study highlights the need for multifaceted intervention strategies that address these issues to enhance HPV vaccine uptake effectively.
(© 2024. The Author(s).)

Vaccine. 2020 Aug 27;38(38):6027-6037. (PMID: 32758380)
Vaccine. 2023 Jan 4;41(1):130-135. (PMID: 36411136)
Front Oncol. 2023 Jun 02;13:1105468. (PMID: 37333817)
BMC Public Health. 2015 Sep 21;15:935. (PMID: 26392084)
JMIR Public Health Surveill. 2022 May 25;8(5):e34715. (PMID: 35421848)
JAMA Pediatr. 2013 Nov;167(11):1065-71. (PMID: 24061681)
Lancet Glob Health. 2020 Oct;8(10):e1335-e1344. (PMID: 32971056)
Prev Med. 2018 Nov;116:203-210. (PMID: 30267734)
BMC Public Health. 2019 Nov 12;19(1):1514. (PMID: 31718611)
Lancet Infect Dis. 2016 Oct;16(10):1154-1168. (PMID: 27373900)
JAMA. 2019 Mar 19;321(11):1041. (PMID: 30874765)
Vaccine. 2019 Apr 24;37(18):2494-2501. (PMID: 30940484)
Front Public Health. 2022 May 12;10:863748. (PMID: 35646758)
Cancer Epidemiol Biomarkers Prev. 2022 Oct 4;31(10):1952-1958. (PMID: 35914738)
CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338)
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 May 10;43(5):702-708. (PMID: 35589576)
J Natl Cancer Inst. 2020 Feb 1;112(2):145-153. (PMID: 31086947)
J Pediatr Nurs. 2023 Jul-Aug;71:73-78. (PMID: 37028228)
Vaccine. 2023 May 5;41(19):3099-3105. (PMID: 37061374)
China CDC Wkly. 2022 Dec 2;4(48):1067-1069. (PMID: 36751370)
Cancer Med. 2019 Oct;8(14):6195-6211. (PMID: 31305011)
Infect Dis Poverty. 2023 Oct 30;12(1):98. (PMID: 37899444)
Vaccine. 2015 Aug 14;33(34):4165-75. (PMID: 25896384)
J Adolesc Health. 2023 Jan;72(1):73-79. (PMID: 36229401)
Lancet Infect Dis. 2022 Dec;22(12):1756-1768. (PMID: 36037823)
BMC Public Health. 2023 Jun 29;23(1):1262. (PMID: 37386430)
Vaccines (Basel). 2022 Jul 26;10(8):. (PMID: 35893833)

INV-018013 United States GATES Bill & Melinda Gates Foundation

Keywords: Adolescent; Human papillomavirus; Influencing factor; Vaccination; Vaccine hesitancy; Willingness

0 (Papillomavirus Vaccines)

Date Created: 20240423 Date Completed: 20240424 Latest Revision: 20240428

20240428

PMC11036762

10.1186/s12905-024-03083-2

38654200